Olympus saw the highest growth of 1.07% in patent filings in May and 1.05% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.94% and grants by 1.05%. GlobalData’s DataBook provides a comprehensive analysis of Olympus‘s patent filings and grants. Buy the databook here.
Olympus has been focused on protecting inventions in United States(US) with 220 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 45% grants. The United States(US), Germany(DE), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Olympus is filings its patents. Among the top granted patent authorities, Olympus has 45% of its grants in United States(US), 27% in China(CN) and 14% in Japan(JP).
Fujifilm could be the strongest competitor for Olympus
Patents related to healthtech and smart hospitals lead Olympus's portfolio
Olympus has the highest number of patents in healthtech followed by, smart hospitals and artificial intelligence. For healthtech, nearly 41% of patents were filed and 32% of patents were granted in Q2 2024.
General surgery devices related patents lead Olympus portfolio followed by diagnostic imaging, and image management
Olympus has highest number of patents in general surgery devices followed by diagnostic imaging, image management, forceps, and healthcare it. For general surgery devices, nearly 48% of patents were filed and 35% of patents were granted in Q2 2024.
For comprehensive analysis of Olympus's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.